The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HIV Diagnosis & Treatment Market Research Report 2024
Synopsis
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
The global HIV Diagnosis & Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
This report aims to provide a comprehensive presentation of the global market for HIV Diagnosis & Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnosis & Treatment.
Report Scope
The HIV Diagnosis & Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Diagnosis & Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Diagnosis & Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Segment by Type
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Diagnosis & Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
The global HIV Diagnosis & Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
This report aims to provide a comprehensive presentation of the global market for HIV Diagnosis & Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnosis & Treatment.
Report Scope
The HIV Diagnosis & Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Diagnosis & Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Diagnosis & Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Segment by Type
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Diagnosis & Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Diagnosis & Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA Test
1.2.3 Saliva Tests
1.2.4 Viral Load Test
1.2.5 Western Blot
1.2.6 Others
1.3 Market by Application
1.3.1 Global HIV Diagnosis & Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Diagnosis & Treatment Market Perspective (2019-2030)
2.2 HIV Diagnosis & Treatment Growth Trends by Region
2.2.1 Global HIV Diagnosis & Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV Diagnosis & Treatment Historic Market Size by Region (2019-2024)
2.2.3 HIV Diagnosis & Treatment Forecasted Market Size by Region (2025-2030)
2.3 HIV Diagnosis & Treatment Market Dynamics
2.3.1 HIV Diagnosis & Treatment Industry Trends
2.3.2 HIV Diagnosis & Treatment Market Drivers
2.3.3 HIV Diagnosis & Treatment Market Challenges
2.3.4 HIV Diagnosis & Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Diagnosis & Treatment Players by Revenue
3.1.1 Global Top HIV Diagnosis & Treatment Players by Revenue (2019-2024)
3.1.2 Global HIV Diagnosis & Treatment Revenue Market Share by Players (2019-2024)
3.2 Global HIV Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Diagnosis & Treatment Revenue
3.4 Global HIV Diagnosis & Treatment Market Concentration Ratio
3.4.1 Global HIV Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnosis & Treatment Revenue in 2023
3.5 HIV Diagnosis & Treatment Key Players Head office and Area Served
3.6 Key Players HIV Diagnosis & Treatment Product Solution and Service
3.7 Date of Enter into HIV Diagnosis & Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Diagnosis & Treatment Breakdown Data by Type
4.1 Global HIV Diagnosis & Treatment Historic Market Size by Type (2019-2024)
4.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Type (2025-2030)
5 HIV Diagnosis & Treatment Breakdown Data by Application
5.1 Global HIV Diagnosis & Treatment Historic Market Size by Application (2019-2024)
5.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV Diagnosis & Treatment Market Size (2019-2030)
6.2 North America HIV Diagnosis & Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV Diagnosis & Treatment Market Size by Country (2019-2024)
6.4 North America HIV Diagnosis & Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Diagnosis & Treatment Market Size (2019-2030)
7.2 Europe HIV Diagnosis & Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV Diagnosis & Treatment Market Size by Country (2019-2024)
7.4 Europe HIV Diagnosis & Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Diagnosis & Treatment Market Size (2019-2030)
8.2 Asia-Pacific HIV Diagnosis & Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV Diagnosis & Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV Diagnosis & Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Diagnosis & Treatment Market Size (2019-2030)
9.2 Latin America HIV Diagnosis & Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV Diagnosis & Treatment Market Size by Country (2019-2024)
9.4 Latin America HIV Diagnosis & Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Diagnosis & Treatment Market Size (2019-2030)
10.2 Middle East & Africa HIV Diagnosis & Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories HIV Diagnosis & Treatment Introduction
11.1.4 Abbott Laboratories Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Cipla
11.4.1 Cipla Company Detail
11.4.2 Cipla Business Overview
11.4.3 Cipla HIV Diagnosis & Treatment Introduction
11.4.4 Cipla Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.4.5 Cipla Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Introduction
11.5.4 F. Hoffmann-La Roche Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Gilead
11.6.1 Gilead Company Detail
11.6.2 Gilead Business Overview
11.6.3 Gilead HIV Diagnosis & Treatment Introduction
11.6.4 Gilead Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.6.5 Gilead Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson HIV Diagnosis & Treatment Introduction
11.8.4 Johnson & Johnson Revenue in HIV Diagnosis & Treatment Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
